Glenmede Investment Management’s Adient ADNT Stock Holding History

Glenmede Investment Management’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$218K	Buy	+9,071	New	+$212K	﹤0.01%	1236

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

Glenmede Investment Management's ADNT Position: Q3 2025 in Review

Glenmede Investment Management opened a new position in Adient (ADNT) in Q3 2025: 9,071 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1236 among its holdings.

287 funds tracked by Wall St. Rank hold ADNT as of Q3 2025.

Glenmede Investment Management held 9,071 shares of Adient worth $218K as of Q3 2025.
Adient was a new Glenmede Investment Management position in Q3 2025.
Adient made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1236 holding.
287 funds tracked by Wall St. Rank held Adient as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.